Award
NIH Reporter #5R01AI174540-03
A role for pharmaceutical control of protease-activated receptor-2 for the treatment of asthma
Recipient
University of Arizona, Tucson, AZ
Award Amount
$761,371.00
Ceiling
$761,371.00
Awarded
June 01, 2026
Identifier
5R01AI174540-03
The award supports research on the role of protease-activated receptor-2 (PAR2) in asthma and the development of new pharmacological treatments targeting PAR2 to address unmet medical needs in asthma therapy.
Description
This project aims to understand the role of epithelial and neuronal PAR2 in allergic asthma and develop pharmacological strategies for asthma protection. It involves in vitro and in vivo studies focusing on novel therapeutics targeting PAR2 as a new treatment approach for asthma.